News | January 29, 2008

Breast Cancer Treatment Is Reduced to One Week

January 30, 2008 - Little Company of Mary Hospital and Health Care Centers in Evergreen Park, IL, has announced it will offer a new clinical study by Xoft using electronic brachytherapy for the treatment of early stage breast cancer, which involves the delivery of a safer form of radiation to breast cancer patients that will reduce the average treatment time from seven weeks to just one week.

Axxent Electronic Brachytherapy System uses a small electronic, low-energy X-ray source that delivers controlled radiation treatment directly to the targeted area. It is similar to another known procedure called Mammosite, but uses a different type of radiation. The Electronic Brachytherapy System uses a balloon-like device, which is implanted at the targeted area. Twice a day for five days, the balloon is expanded and a miniature X-ray tube is inserted.

Little Company of Mary is the first community hospital in Illinois to offer the study, joining only nine other sites in the country that offer the treatment.

The study’s principal investigator, radiation oncologist Adam Dickler, M.D., said the major benefit for patients is the largely reduced treatment time, which would help many women receive the treatment they need without having to undergo therapy for seven weeks. A key component that sets this therapy apart is that electronic brachytherapy uses an electronic source of radiation instead of radioactive isotopes. This allows the X-ray source to be turned on and off at will, and benefits patients because of its decreased radiation exposure to vital organs such as the heart and lungs.

Another advantage includes the change in treatment settings. Patients will now be able to receive their treatments in a comfortable room setting with their physician, instead of being separated in a shielded room alone while the physician distributes the treatment from another area.

Axxent Electronic Brachytherapy System is approved by the FDA for the treatment of early stage breast cancer. Women who are in this stage and are over the age of 50 may be eligible to participate in the study.

For more information: www.PursuingPainFreeCancer.org/breastcancer

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...